TCMD (Tactile Systems Technology) Change In Working Capital : $7.7 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Change In Working Capital?

Tactile Systems Technology's change in working capital for the quarter that ended in Mar. 2025 was $-0.7 Mil.

Tactile Systems Technology's change in working capital for the fiscal year that ended in Dec. 2024 was $7.7 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Tactile Systems Technology Change In Working Capital Historical Data

The historical data trend for Tactile Systems Technology's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Change In Working Capital Chart

Tactile Systems Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Working Capital

Get a 7-Day Free Trial

-12.76

-9.46

-4.63

15.10

7.71

Tactile Systems Technology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Working Capital	Get a 7-Day Free Trial															-0.62	5.33	1.35	1.65	-0.66

Tactile Systems Technology Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.7 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Tactile Systems Technology Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tactile Systems Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

3L3:Germany

Address

3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website

https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Executives

Daniel L. Reuvers	director, officer: President and CEO	INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Elaine M. Birkemeyer	officer: Chief Financial Officer	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Kristie Burns	officer: Sr. VP Mktg & Clinical Affairs	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sherri Lee Ferstler	officer: Senior VP, Sales	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke	director	3868 MOCKINGBIRD LN, DALLAS TX 75205
Boyd Vindell Washington	director	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Eric Pauls	officer: Senior VP, Sales	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen	officer: Chief Financial Officer	3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe	officer: Vice President, Sales	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Sheri Louise Dodd	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Gerald R. Mattys	director, officer: Chief Executive Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413